UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 6, 2010
WRIGHT MEDICAL GROUP, INC.
(Exact name of registrant as specified in charter)
| |
|
|
|
|
| Delaware
|
|
000-32883
|
|
13-4088127 |
| (State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of incorporation)
|
|
File Number)
|
|
Identification Number) |
| |
|
|
| 5677 Airline Road, Arlington, Tennessee
|
|
38002 |
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (901) 867-9971
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01.
Other Events.
On January 6, 2010, we announced that, after a review of our current management structure, we have
entered into discussions with Paul R. Kosters, President, Europe, Middle East, and Africa (EMEA),
regarding a change in his position. We hope to finalize these discussions soon. During this period
of discussions with Mr. Kosters, Cary Hagan, Vice President, OrthoRecon Marketing, has been
appointed as the interim leader for EMEA.
1